InVivo raising $14M for spinal trial; Argon rolls out dialysis tech;

@FierceMedDev: Mindray Medical revenue jumps up by 9% in Q1. More | Follow @FierceMedDev

@VarunSaxena2: Apple on medical tech hiring spree, a possible hint of iWatch plans. Story | Follow @VarunSaxena2

@EmilyWFierce: California high court to decide whether retailers should have defibrillators on hand for stricken customers. Article | Follow @EmilyWFierce

@MichaelGFierce: Icon's Verisome-delivered cataract inflammation treatment enters PhIII. Release | Follow @MichaelGFierce

> InVivo ($NVIV) is raising $14 million to help complete the long-delayed study of its Neuro-Spinal Scaffold. News

> Argon Medical Devices has launched its CleanerXT Rotational Thrombectomy System, part of its franchise of dialysis devices. Item

> Qiagen ($QGEN) picked up FDA clearance for its latest C. difficile diagnostic. More

Biotech News

@FierceBiotech: AstraZeneca promises investors a magnificent future--without Pfizer. Story | Follow @FierceBiotech

@JohnCFierce: Some of the new OKs at Merck won't amount to much, some will. Collectively, though, it's a breakthrough. Great to see. | Follow @JohnCFierce

@DamianFierce: Breakthrough melanoma prospect MK-3475 has an FDA decision date set for Oct. 28. Release | Follow @DamianFierce

@EmilyMFierce: Hormone could be key to reversing the aging process. More | Follow @EmilyMFierce

> Loxo lands $24M venture round and a CSO for cancer drug research. Story

> Merck pays $1B to buy into Bayer's cardio future. Article

> AstraZeneca promises investors a magnificent future--without Pfizer. Report

Pharma News

@FiercePharma: Cancer-drug market zooms toward $100B, thanks to costly targeted therapies. Article | Follow @FiercePharma

@TracyStaton: Convicted U.S. soldier blames Pfizer's controversial stop-smoking drug Chantix for inexplicable murder. Story via McClatchy | Follow @TracyStaton

@EricPFierce: CEO says Teva will close at least 11 plants, 15% of its network, and 16 more are being evaluated. Story | Follow @EricPFierce

@CarlyHFierce: ICYMI yesterday: Sanofi's Shan5 overcomes manufacturing setback to score thumbs up from WHO. More from FierceVaccines | Follow @CarlyHFierce

> Loud opposition to Pfizer's AstraZeneca takeover prompts Parliamentary probe. Story

> Bayer aims to crush consumer health rivals with $14B Merck unit buyout. More

Biotech Research News

> UCSF, Stanford and Johns Hopkins join FDA partnership to speed drug development. More

> Fast-acting antidepressant shows continued relief in animals. Story

> Technique aims to more accurately test pharmaceuticals. Item

> Harvard's bone marrow-on-a-chip could replace animal drug testing. Article

> Novavax, U. of Maryland report positive preclinical results for MERS vaccine. More

Pharma Manufacturing News

> Sanofi's Shantha Biotechnics gets manufacturing issues resolved. News

> Caraco plant in Detroit being shut down by Sun Pharma. Article

> FDA smacks Mexican facility that makes scorpion antivenom for U.S. Story

> Italian mafia at center of network that stole vials of Roche's Herceptin. Report

> Teva whacking 11 plants for sure, another 16 being evaluated. More

Suggested Articles

The FDA has cleared its first fully disposable duodenoscope, following years of reports of infections being transmitted between patients.

OR-focused AI provider Caresyntax has garnered $45.6 million in new funding and picked up a data analytics firm to broaden its footprint.

A study of Foundation Medicine’s FoundationOne liquid biopsy test found it was able to predict the risk that a person’s breast cancer would return.